ArticleImmunology2015

A polymorphism in a phosphotyrosine signalling motif of CD229 (Ly9, SLAMF3) alters SH2 domain binding and T-cell activation.

Stefanie Margraf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.